ArticleBritish journal of cancer2024

Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification.

Xiaoxiao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.